Clinical trial
The Role of Gut-oral Axis Microbiome in Autism Spectrum Disorders
NCT05830591 is registered in ClinicalTrials.gov with IRCCS Burlo Garofolo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of Gut-oral Axis Microbiome in Autism Spectrum Disorders
- Lead sponsor
- IRCCS Burlo Garofolo
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- May 20, 2021
- Completion date
- December 31, 2024
- Enrollment
- 86 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autism spectrum disorder, microbiota